secwatch.observer — SEC 8-K summary
======================================

Issuer:     AETHLON MEDICAL INC (AEMD)
CIK:        0000882291
Form:       8-K
Filed at:   2025-09-09T23:59:59+00:00
Accession:  0001683168-25-006788
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aethlon Medical prices $4.5M public offering of common stock and warrants at $0.90/unit
--------------------------------------------------------------------------------

- Gross proceeds of $4.5M; net to company ~$3.9M after placement agent fees and expenses.
- Offering includes 5M shares (or pre-funded warrants) and 5M warrants exercisable at $0.90 for 5 years.
- Maxim Group acted as exclusive placement agent; 6.25% cash fee ($281,250) and 200,000 warrants.
- Net proceeds to be used for working capital, clinical trial and R&D expenses.
- Officers and directors subject to 60-day lock-up; company has 90-day issuance standstill.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882291/000168316825006788/0001683168-25-006788-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882291/000168316825006788/aemd_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-006788

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer